Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GREAT NEWS OUT BY EAPH - This should put a damper on the people who keeps saying negative things that are not true about Easton and it's directors. They just advanced $575,000 towards medical marijuana and other revenue for Canada. A great press release which is on top of the great news last week from Gedeon Richter. Management is doing a great job bringing shareholder value into this company. They're spending a lot of money and it is all going to be shown and reflected in its spot price shortly. Every stock has its day, and Easton has way more going for at the 95% of the OTC companies who have much larger market caps.
Once the news on a closed agreement with Bayer pharmaceuticals comes out, this stock will be a huge winner for anyone holding shares in Easton.
Catalyst for big run up similar to SING is sooon at hand. Solid huge news is shortly at hand. Bayer Pharmaceuticals announcement is imminent. Press release on contracts with Alliance partners property is imminent. Easton has advanced over $500k to this. News any day now. possible medical marijuana approval for cultivation of marijuana for Canada is just maybe weeks away. If that happens then you pick any number above $.20 cents.
Enjoy the summer as I predict a very good fall season.
!!!GO EAPH GO!!! EAPH and its CEO Evan Karras are doing some incredible things. Easton has received Purchase orders in the last quarter of $400,000 which is after only 3 months of product launch. It takes time to grow a product which means millions in sales is what to expect. Now EAPH have launched a second product with a multi-national billion dollar Pharmaceuticals company (Gedeon Richter).
Bayer Pharmaceuticals is the next big agreement and announcement which after the name Bayer is finally announced will be the catalyst towards a $.20 cent stock IN THE NEAR TERM.
IBliss agreement is finalized and the next quarter will show those sales on EAPH's financial statements.
But the biggest news of all could be a growop and a cultivators license for Canada. Evan Karras has said that is only a short wait away.
My friends, don't listen to outside crap but read the company's press releases and financial statements to here accurate information.
GO EAPH GO!
Here are the facts. Easton has already disclosed in a very quiet manner, that they've accepted and come to terms with a major international pharmaceutical company. They have already hinted and I believe they've already said that that company is Bayer pharmaceuticals who are selling the same product in Europe. As they stated, they're just waiting for a final agreement which unfortunately depends on these companies and the fact that they work very very slow. When news hits on that, you tell me if the stock is undervalued.
The company and Evan Karras has also stated that they have closed on an agreement for medical marijuana in Canada on 45 acres of land and secured by property value that is worth several millions dollars and revenues from other businesses on that property. What do you think the price is worth when that comes out.
As for anyone else who likes to put out inaccurate information on the company and its business, look at Easton's financial statements and you will see the hundreds of thousands of dollars invested on licensing fees for their diagnostic and women's treatment division which is now into revenues.
Every stock has it's day, and I am convinced that Easton will once again be in the good eye of investors. Give it time and if they execute on their business plan and do as they hope which includes IBliss and their revenues then the stock could move up significantly just as AMFIL has.
EAPH WILL NOT BE UNDERVALUED FOR LONG. HERE ARE THE FACTS. EASTON HAS ALREADY DISCLOSED THAT THEY HAVE RECEIVED $400,000 IN PURCHASE ORDERS DURING THE LAST QUARTER. THAT WILL MOST CERTAINLY BE SHOWN IN TVE NEXT QUARTERLY STATEMENTS DUE IN 1 to 2 WEEKS.
EASTON HAS SPENT $800,000 IN CAPITAL TOWARDS ACQUIRING LISCENCES. THAT IS COLD HARD CASH AND NOT NEW SHARE ISSUANCES AS OF YET.
SECOND PRODUCT KAUNCH WITH MAJOR PHARMACEUTICAL COMPANY. THIRD PRODUCT LAUNCH IS READY TO BE SIGNED WITH HUGE MULTI-NATIONAL PHARMA COMPANY. EASTON DOING BUSINESS WITH BIG COMPANIES SHOWS THAT THEY HAVE CREDIBILITY AND REAL PRODUCTS.
IBLISS BEING RENEGOTIATED ON CERTAIN TERMS. BUT THE MAIN DELAY HAS BEEN A BEW ACQUISITION REGARDING CULTIVATION OF MEDICAL WHICH WILL SOON BE RECREATIONAL MARIJUANA IN CANADA. ONCE THAT IS ANNOUNCED EXOECT A $.20 CENT STOCK.
MY FRIENDS I PREDICT A BIG PAYDAY FOR ALL LING SHAREHOLDERS.
I predicted a good run up of EAPH by end of September which I said 2 months ago and I am still predicting this. GREAT news today with second product launch with tons of great news to follow.
The last quarter had Easton confirm $400,000usd in purchase orders. Now we have a second product launch with a multi-billion dollar Pharmaceuticals company (Gedeon Richter)as its salesman.
Soon we will get news on Bayer on a third product which is the catalyst to have the stock explode.
Soon we will have news out on medical marijuana in Canada where its legal. A legal growop for MMJ is soon at hand.
The wait will soon be over for all longs.
If all goes as planned, with Easton and her partner at alliance, Easton will have a medical marijuana growers license in hand within 60 days. To be frank, the company knows that if it gets that license, the stock price won't matter. But to shareholders It will be north of $.50 and millions of shares of volume. I don't have all the details in front of me as the company is very hush-hush about it, but the application has been submitted through alliance partners and everyone believes EAPH and alliance will get an approval by the end of September. For all the moms out there, the marketmakers are just playing games at the moment. The stock price will get to four cents within a day in much higher with the next few cross releases
McKinley, sorry I didn't respond to you and your private message, but unfortunately I'm not a premium subscriber anymore due to various reasons with ihub.
****Prediction***** Although my prediction of $.15 cents has not yet happened I will still maintain it. From where the company stock is presently trading, any shareholders buying in at this point will make a conservative profit of 100 to 200%. Having said that, the company has not only closed contracts pending and ready to be announced which includes Bayer pharmaceuticals which they have already disclosed is the company soon to be announced, if they close on the discussions that they are having now regarding medical marijuana in Canada, EAPH will be a $.25 stock by the end of September. Easton will be a huge play in the near term. Near term means end of September.
Revenues are ramping up and will only keep growing. This doesn't include IBliss acquisition which EAPH said they updated. Everything is moving forward and shows how undervalued this company is.
Bayer Pharmaceuticals deal is short at hand for 3rd product launch.
As I've stated many times before, don't listen to anyone on here with their own agendas. Do your own due diligence, which means look at the companies press releases and contact the company by email to get accurate information. Today's press release is proof that they are moving forward positively on all fronts. Evan Karras is doing a great job as CEO with many other quality announcement soon to follow.
The stock will soon be at $.15. But don't look at $.15 or 15 times your money. Where else can you double your investment from where it is now which is a conservative number.
GO EAPH GO.
Great IBliss news soon to explode the stock. Anyone not buying stock at this price will be kicking themselves in the next little while.
Great alliance news including revenues which are secured against a mortgage on the property. Anyone not buying stock at this price will be kicking themselves in the next little while.
Great news soon to be announced regarding the closing agreement with royalties with Bayer pharmaceuticals. Yes the heavyweight pharmaceutical giant is doing a deal with small Easton.
Anyone not buying stock at this price level will be kicking themselves in the next little while. Apple or Google or any other large cap stock will not double and quadruple your investment within a short few weeks.
#EAPH has cash and generating sales which will be shown on the next quarterly statement.
They have a new product launch announcement to make very shortly once they get their import export Permits which are due in the next week or two
They have an agreement pending which is just waiting for the attorneys to approve from Bayer pharmaceuticals which as they stated will provide the company with a royalty and upfront cash payment.
They have acquisitions pending that will immediately generate revenues which does not include the already closed acquisition of I IBliss.
After all this, the company has no concerns about the stock price. They are already financed.
$.15 in the next little while is still my prediction. There are many things on the goal with this company, most of which they have already provided information on, such as Bayer pharmaceuticals and a new product launch, which will propel the stock very very quickly to new highs. Don't get left in the dust when it happens. Do your own due diligence, speak to the company, read their financial statements and don't listen to any other crap from people who are not shareholders and never were shareholders. A lot more consistent positive news on IBliss is short at hand. Revenue projections I have been told will be provided soon enough that are consistent and growing.
Long and strong
The long term trend for EAPH is up. I dint care what the non shareholders say or what anyone else say, this stock will rebound and it will rebound very very fast. It will make new highs and that will happen in a short period of time.
The news and revenues they have lined up will abruptly turn this stock to $.04 cents with 2 days of the announcement and towards $.15 cents with 2 weeks. Revenues and contracts will drive this to new highs and that is soon at hand
New PO From Gedeon Richter to be announced as sales of Gynofit are ramping up.
Second product launch through Bayer Pharmaceuticals. Third product launch through Gedeon Richter to be announced proving that the relationship with Gedeon is going well.
IBliss and New revenues generating acquisition to be announced.
Long and strong
Big news is soon to be announced which I believe is a closing agreement with Bayer and Royalties. This will instantaneously shoot the stock price up and start the trip up to $.15 cents.
Investors should not panic. Easton is not into pump and dumps which is why no PR company's have been engaged. Easton has cash in hand as previously announced and has started sales through Gedeon Richter and Gynofit.
A new PO will soon be announced through Gedeon Richter for Gynofit. A new product launch through Gedeon Richter will soon be launched. So the stock price is not a concern by Easton. The torch will soon be lit.
$.15 cents is a certainty based on an investment fund ready to buy in and contracts with multi-national drug company's. 2 multi-national drug company's. they also have Acquisitions ready to. Lose with solid profits and contracts that will expand sales to over $20,000,000.
There is also an investment fund ready to jump in but has waited for confirmation of something which I cannot disclose but it is soon at hand.
The long term holders will soon be very well rewarded as The time is soon at hand. Only read the press releases from the company to know what's real and not anything else.
They invested cold hard cash to purchase products which they then made a sub distribution agreement with Gedeon Richter. A second PO is pending.
They invested cold hard cash for VS -Sense and AL-Sense and have the agreements with Royalty payments on the table from Bayer Pharmaceuticals.
Once they announce Bayer, where do you think this stock is valued and this does not include IBliss and their $15,000,000 in sales and other acquisitions.
Buy and hold is correct as someone on this board eloquently stated. EAPH will have its day again. Lots of great news regarding IBliss and a second and third product launch in Mexico and Latin America through multinationals such as Bayer and Gedeon.
No one on this board should listen to what stated here especially by the trolls who are not investors. Do your own due diligence. Read the press releases, call the company, look at their financial statements and see that there is no dilution. Easton is looking out for the shareholders by entering into an agreement with IBliss through part cash and shares advanced through performance milestones.
It's just a matter of time before the stock takes off and everyone will be very happy that they held on and were shareholders. Easton is highly under valued at this point with all the great things they have going on. They are on track for $15 million in sales revenues hopefully by the end of this year. If that doesn't tell you that Easton is way way undervalued then I don't know what does.
Long and strong
$.15 cents is just a matter of time as it's way undervalued . IBliss has profits and is on track for $15,000,000 in sales.
The Israeli based company already has sales and has patent pendings. $20,000,000 in sales projected within 3 years. Considering how potash is a multi- billion dollar company which Bayer just recently purchased, I would say it's a great acquisition target. If it's good enough for Bayer it's good enough for Easton.
EAPH also said in the same press release that Gedeon Richter is forwarding another PO for Gynofit.
EAPH also said they will have 2 more product launches with 2 more multinational Pharmaceutical company's. you can bet that Bayer is one of them as they mentioned their name in the release.
This stock is way undervalued but will soon be at $.15 cents at minimum.
GO EAPH GO
It's great news. $$.15 cents soon at hand. The Israeli based company already has sales and has patent pendings. $20,000,000 in sales projected within 3 years. Considering how potash is a multi- billion dollar company which Bayer just recently purchased, I would say it's a great acquisition target. If it's good enough for Bayer it's good enough for Easton.
EAPH also said in the same press release that Gedeon Richter is forwarding another PO for Gynofit.
EAPH also said they will have 2 more product launches with 2 more multinational Pharmaceutical company's. you can bet that Bayer is one of them as they mentioned their name in the release.
This stock is way undervalued but will soon be at $.15 cents at minimum.
GO EAPH GO
Be patient. A catalyst to spark this stock to new highs towards $.15 cents is soon at hand.
Second product launch with possibly Bayer Pharmaceuticals is very short at hand.
Third product launch is very short at hand with Gedeon Richter.
Gedeon Richter to order a second round of product within the next week.
IBliss is moving towards $15,000,000 in sales with 40 percent profit margins. Lots of news ready to come out through iBliss.
Stock is way way undervalued but not for long as the catalyst to launch this is another acquisition announcement.
!!GO EAPH!! It's closed which further demonstrates Easton as being a so kind revenue producing company. They now have sales through iBliss and through Gedeon Richter which is why an auditor is now required. No company needs to be audited unless they have sales which Eastonpharma now has.
I now hear that another big announcement is set for Monday. $.15 cents shortly. !!Go EAPH!!
$.15 cents very very soon. Don't listen to any of the garbage being said. IBliss will be officially 100% closed and announced this week. Terms on acquisition will be disclosed and they are good terms for Easton and its shareholders. IBliss is on track for $15 Million in sales. That means profits of $6million to $7 million.
Next acquisition will blow everyone's mind. Then you will have major news coming from iBliss including a medical marijuana growers license for the country of Canada.
Then you will have a second followed by a third product launch through Bayer pharmaceuticals and another multibillion dollar company which takes the stock to $.30 cents or it should.
Anyone not buying stock now or listening to the garbage of lies will be deeply upset in the next short while. I am giving you my prediction and I've been right before. And I will definitely be shown that I will be right again
LONG
$.15 cents very very soon. Next acquisition will blow everyone's mind. Then you will have major news coming from iBliss including a medical marijuana growers license for the country of Canada.
Then you will have a second followed by a third product lunch through Bayer pharmaceuticals and another multibillion dollar company.
Anyone not buying stock now or Celine old now, will be deeply upset in the next short while. I am giving you my prediction and I've been right before. And I will definitely be Sean that I will be right again
$.15 cents very shortly and $.30 cents in 60 days. Wait till you see the next acquisition announcement from Evan Karras regarding a great revenue producing Pharma business in Florida. We will then not hear anything more from trolls.
Or how about a second product launch with Bayer Pharmaceuticals and then a third to follow with another multi- billion dollar pharmaceuticals company.
IBliss will have several announcements and regular updates including medical marijuana growers license for Canada which will soon have legalized recreational marijuana.
$.15 cents is soon at hand.
Wait till you see what Evan Karras has lined up next for an acquisition. That announcement makes EAPH a $.30 cent stock.
Full details later this week. 2 nd product launch is coming with what should be Bayer as a partner. Then 3rd product launch thereafter.
IR company starting next week.
News is being prepared. Here why $.15 cents is realistically close at hand.
iBliss will close. From what I have been advised, iBliss is projecting to reach $15,000,000 in sales which they previously had.
iBliss is heavily involved in MMJ and will be part of Canada's legalization of recreational medical marijuana which may be bigger than everything else together.
Easton is days away from signing agreement for second product launch through a multi billion dollar pharmaceuticals company. I suspect it will be with Bayer.
If they close on just one of these agreements, the stock will be at $.15. If they close both agreements Easton will be a $.30 stock
Long and strong. Your patience will pay off.
Here's a fact. $.15 cents shortly. That is a fact that will happen. And example is Easton's partner AMFIL technologies who they are in discussions with And his financing Easton through the great investment they did with them three years ago. Easton will soon be in revenues through iBliss which previously had sales of 15 million per year and presently at 8 million per year. But they are now growing again and are expected to be at $15 million by the end of this year
We already know they are currently into revenues through Gedeon Richter which will only grow.
They will be signing a closing agreement with another multibillion-dollar Pharma company for the launch of a second product.
They are currently in discussions with Bayer pharmaceuticals and will have a closing agreement with them shortly. That is fact. Why is that the case, because they have products that Bayer are currently selling around the world and they want additional territories which they can only get by acquiring it through Easton.
Don't listen to anyone who is not even an investor but just continuously six day after day talking garbage. Look at the facts and do your own due diligence. Why did Easton make a deal with a multibillion dollar company. It's because they have product that's in demand.
EAPH WILL BE $.15 CENTS ON WHAT IS BEING SIGNED AND POSSIBLY $1.00 IF THEY CLOSE ON WHAT THEY ARE IN NEGOTIATIONS ON.
$.15 cents is soon at hand. It takes one announcement to do it. Easton has many announcements lined up, but it first needs iBliss to close. I was told from someone at both iBliss and Easton that it will close. IBliss is getting a good deal from Easton as they are getting cash up front. IBliss has solid sales.
Second agreement for second product with multi-national drug company is out for signing. I suspect this is Bayer.
Anyone of these announcements will propel the stock to new highs. I predict $.15cents in the short term.
Final agreement has been sent to iBliss. It's already been agreed to. It could be all signed up on Monday and ready to announce later this week .
The next press release after the iBliss closing is all the big MMJ news that iBliss brings.
The announcement after that will be the launch of a second product with Bayer Pharmaceuticals.
$.15 cents is soon at hand. $.30 cents in 60 days.
Final agreement sent to iBliss. Should be signed on Monday.
iBliss or another contract is expected to close Thursday or Friday if this week just as Easton tweeted. One Closed agreement this week just as the company has stated. New contracts for new product launches. Easton has access to cash which will result in closed agreements for revenue generating acquisitions.
IBliss is closing. EAPH will soon be at $.15 cents. If Easton closes on any of the other things they are doing which one of them will close which includes a multibillion dollar pharmaceutical company to launch a second product in Latin America, Easton will be at $.30 cents. Long and strong
Don't listen to the naysayers and the critics as we all know who they are. Eastern already made a deal with a multibillion dollar pharmaceutical company. That already demonstrates that they have the credibility to negotiate with real companies and that they have real Products. Evan Karras is doing a fantastic job for Easton.
Apple will not double from here. But Easton surely can.
LONG AND STRONG
$.15 cents in 6 weeks. What's a sure thing is closed agreements for iBliss and launch of second product with Multi billion dollar pharmaceutical company. I suspect it's with Bayer. Don't be swayed by the naysayers and critics.
!!Done deal!! Easton to sign iBliss closing no later than next Tuesday. Expect new highs shortly.
Expect a closed deal for launch of second product with multi-billion dollar Bayer Pharmaceuticals by the end of next week.
Expect another BIG acquisition very soon.
Expect new highs of $.15 cents very soon.
Great things happening behind the scenes with EAPH. I'm also hoping they get news out on Wednesday to get the momentum cranked. But if it's not Wednesday then it's any day. Significant news is imminent. We need to stay strong and positive as Easton has already told us what's in the pipeline. It's just a matter of which deal they choose. But Sometimes no deal is the best deal. But what I do know for sure is that they will soon launch a second product with a multinational.
Just Got off phone with Evan Karras. He alluded to possible news for tomorrow morning. This will provide detailed update as well as some very positive news which he couldn't elaborate on.
Easton Is Set To Take Flight again after they finally resolved a big hurdle last Friday with a big payment made to the license owner. This now paves the way to close on and launch a second product with a multi-national, multi- billion dollar drug company.
And in case someone doesn't understand this, multi billion dollar drug Company's don't launch new products to make a few hundred thousand dollars.
Third product is nearing completion and launch with a second multinational, multi billion dollar, much larger drug company. Friday was a big day because it allowed all these products to no close on agreements.
NEW Distribution contract with multi billion dollar Pharma company for second product launch is now set to go. A big hurdle was passed yesterday with payments made. Expect good news very very shortly once they get it approved from head office.
Great News On Easton Contract Falinski. Soon enough, days not weeks, we shall finally get to see another product launch from a multi-billion dollar Pharma company. As you and others have said many times. Multibillion dollar pharmaceutical companies do not launch products to make a few hundred thousand dollars. In addition, they don't put their names beside small company's such as Easton unless they have real products. Anyone saying otherwise is just stupid